Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Article
Development and Validation of a Risk Score Predicting Medication Non-adherence in Patients with Heart Failure
Tomoaki Ishida Kei KawadaKohei JobuTomoyuki HamadaToru KuboYuki HyohdohMoemi OkazakiTakaya SagawaKazuya KawaiYoko NakaokaToshikazu YabeTakashi FurunoEisuke YamadaYayoi KawanoHiroaki Kitaoka Yukihiro Hamada
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML
Supplementary material

2026 Volume 49 Issue 2 Pages 327-334

Details
Abstract

In this study, we aimed to develop a clinically applicable risk score using demographic and clinical data available at hospital admission for decompensated heart failure (HF) to identify patients at high risk of medication non-adherence after discharge. In total, 795 patients with HF were enrolled from a prospective, multicenter cohort study. A logistic regression model identified independent predictors of medication non-adherence leading to hospitalization, and we derived a risk score from the partial regression coefficients of these factors. Hospitalization due to medication non-adherence occurred in 6.4% of patients. Independent predictors included dementia (odds ratio [OR]: 2.79; 95% confidence interval [CI]: 1.38–5.65), male sex (OR: 2.50; 95% CI: 1.30–4.79), current smoking (OR: 2.17; 95% CI: 1.07–4.41), non-assisted living (OR: 2.14; 95% CI: 1.17–3.94), and prior HF hospitalization (OR: 1.91; 95% CI: 1.05–3.46). The predictive model showed good discrimination (area under the receiver operating characteristic curve = 0.704). Patients with higher risk scores (4–6 points) had significantly higher rates of all-cause and cardiovascular mortality over 2 years. In conclusion, this pragmatic, admission-based risk score enables early identification of patients at risk for medication non-adherence and may support targeted interventions to improve long-term HF outcomes. Incorporating this score into routine admission processes may help prioritize adherence support for high-risk patients, guide multidisciplinary care planning, and reduce post-discharge complications in HF management.

Fullsize Image
Content from these authors
© 2026 The Author(s).
Published by The Pharmaceutical Society of Japan

This article is licensed under a Creative Commons [Attribution-NonCommercial 4.0 International] license.
https://creativecommons.org/licenses/by-nc/4.0/
Previous article Next article
feedback
Top